Introduction
In situ hybridization (ISH) has been developed on the principles of nucleic acid hybridization procedures that were developed to detect DNA or RNA in tissue extracts. ISH was initially developed with radioactive probes that detect nucleic acids by autoradiography. The use of radioisotopes can have several disadvantages that limit the sensitivity and the application of ISH. This triggered early efforts to develop molecules and procedures that would allow the detection of DNA or RNA in tissues with non-radioactive probes (3,5,14,24). Non-radioactive probes have many advantages compared with radioactive probes. The absence of radioactivity avoids many inconveniences linked to the use of radioisotopes, especially the biohazards, expenses, and procedures required to protect against radioactivity. The use of nonisotopic probes avoids autoradiographic procedures that are tedious, time-consuming, expensive, and difficult to organize on a routine basis. Non-radioactive probes have an almost unlimited shelf-life and can be used months and years after preparation, impossible with 32P-, 35S-, and 33P-labeled probes. In addition, non-radioactive probes provide results within hours after completion of the ISH, whereas radioactive probes need days, weeks, or months of latency.
When the information provided by ISH is considered, the nonradioactive probes are also superior to radioactive probes. They give optimal cellular and subcellular resolution, with the reaction limited to the cell compartment containing the nucleotide target, at both the light (LM) and electron microscopic (EM) levels. This resolution is difficult to obtain with radiolabeled probes, especially with those containing a high-energy radioisotope (e.g., 32P, 35S). Non-' radioactive probes can be prepared in several ways that include incorporation of a reporter molecule inside the probe. The labeled probes are then detected by histochemical and/or immunohistochemical procedures (3). Biotin and digoxigenin are the most widely used because they are the most efficiently detectable markers for oligonucleotides, cDNAs, and riboprobes.
Since 1988 we have used biotinylated probes for detection of RNAs in heterocellular tissues such as those of the CNS (4,9, 10,17,21). Here we describe and review protocols for the use of biotinylated probes and their applications and limitations for ISH.
Description of Methods and Protocols
Biotinylated ISH probes were first introduced in the early 1980s by Ward and colleagues (5,24). They developed dUTP derivatives (allylamine dUTP) to which biotin was covalently linked by a carbon spacer arm. It appeared that biotinylated deoxynucleotides could be incorporated into DNA with-, out substantial modification of hybridization properties, especially the thermal stability of the modified DNA. Biotinylated probes can now be obtained in several configurations. The biotin can be attabhed at the 3' or the 5' end of oligonucleotides during chemical synthesis (6,9,12). Photobiotin can also be covalently linked to probes (8,29). Certain biotinylated probes are commercially available, including probes for detecting viral genomes and various mRNAs (Dako, Santa Barbara, CA; Enzo Biochem, New York, Ny; Sigma, St. Louis, MO). The most common procedure for obtaining biotinylated probes involves incorporating biotinylated nucleotides or deoxynucleotide derivatives inside the probe. Several companies (Enzo Biochem; BRL, Gaithersburg, MD; Clontech, Palo Alto, CA) now provide such molecules that vary according to the length of the carbon spacer arm linking biotin to the nucleotide. Synthetic oligonucleotides can incorporate biotinylated deoxynucleotides by tailing at their 3' end with terminal deoxynucleotidyl transferase, as initially described by Guitteny et al. and modified by Normand and Bloch (9,21). cDNAs can be labeled by ni&-translation (2,5,14,17,27). Riboprobes can be synthesized by transcription from the ap-BLOCH propriate template (8.23). The level of incorporation of biotin and the appropriate concentration and quantity of probe can be established by testing those parameters directly in ISH experiments (3.9). Alternatively, it is possible to measure the level of incorporation by in vitro tests (12) . In our hands, biotinylated oligonucleotides and cDNA probes are used at concentrations ranging from 1.5-6 ngllOO pl and 6-12 ng/lOO pg, respectively, while the same 3'S-labeled probes are used at concentrations ranging from 0.2-0.6 ng/100 pl and 2-6 ngllOO kl, respectively. Biotinylated probes can be easily stored at -20°C in the hybridization buffer for weeks or months.
There are no specific requirements for fixation when mRNAs are detected with biotinylated probes compared with detection with radioactive probes (7, 9, 28) . In addition, hybridizations and post-hybridizations are performed with the same conditions as radioactive probes. Various refinements of histochemistry and immunohistochemistry can detect biotin (19.25) : (a) antibiotin followed by a secondary antibody linked to fluorescein (14) , peroxidase (16) , or gold particles (2); and (b) avidin (6, 12, 25, 26) or, preferably, streptavidin (7, 9, 19, 21) to which is attached a marker (fluorescein, peroxidase, alkaline phosphatase). Avidin and streptavidin have extraordinarily high affinity for biotin (lo-'' M). One molecule of avidin or streptavidin can associate with four biotin molecules. Amplification systems using multistep procedures or other refinements improve the sensitivity of the technique (6, 19, 25) . The use of streptavidin linked to alkaline phosphatase with bromochloro-indolyl phosphate and nitroblue tetrazolium as the substrate is presently one ofthe most efficient and sensitive ways to detect "As with biotinylated probes at the LM level ( 6.9,10,12,19,21,25,26) . Gold particles or peroxidase provide exquisite subcellular resolution for EM (2, 16, 18, 27) .
Controls. Controls must be performed to ensure probe specificity and ISH signal specificity but are frequently omitted or only partially done. Nonspecific signals may occur even with specific probes and can have various origins, including the presence of endogenous biotin or alkaline phosphatase in tissues (11) , inappropriate biotin incorporation, inappropriate fixation or storage of the tissues, necrosis, pigments (especially in human samples) (28) , and inappropriate hybridization procedures.
Controls can be performed in several ways: (a) omitting the biotinylated probe or avidin in the procedure (12); (b) ensuring that several probes for the same mRNA produce identical signals; (c) comparing hybridization signals obtained for different mRNAs in the same tissue; (d) using the probe for a Northern blot (12) ; (e) comparing results of ISH and immunohistochemistry (10,12); (f) using sense probes (for cRNAs); (g) using RNAse pre-treatment of the sections (12); and (h) ensuring that dose-dependent decrease and disappearance of the signal are obtained when increasing concentrations of the unlabeled probe are added (9.12).
Advantages and Unique Features
Biotinylated probes for ISH can be used for many objectives. They can be used to analyze the cellular and subcellular localization of messenger RNAs at the LM or EM level (2,4,7,10,14,16,24,27) (Figure 1A) . This is especially important for detecting mRNAs in neurons ( Figure 1B ) and other highly compartmentalized cells, where localization of radioactive probes is less precise (4). Biotinylated probes can be used with cryostat or Vibratome sections (4, 9, 17) , cultured cells (14, 23, 24) , and tissues embedded in paraffin or plastic (2,5,6,10, 16, 18, 27) . It appears that a biotinylated probe hybridized to its corresponding mRNA is unaffected by plastic-embedding procedures and can be detected in semi-thin plastic sections, thus providing optimal subcellular resolution of the signal and the possibility of correlative immunohistochemistry (10) (Figures lC, lD , and IF). Biotinylated probes are also useful in a pathology laboratory for routine detection of viruses in tissue sections, since the results are obtained quickly without the use of radioisotopes (5,18,26) (Figure 1G-H) .
Biotinylated probes can also be used in combination with immunohistochemistry (1,10,13) (and/or neuronal tracing or receptor detection) to obtain information about gene activity in identified cell populations ( Figures 1C and 1E) . Combining non-radioactive ISH with immunohistochemistry on the same ( Figure IF) or adjacent sections ( Figures 1C and 1D ) provides information on both transcriptional and translational activity of cells (10.12) . Detection of two mRNAs by combination of a biotinylated probe and a radioactive probe is especially useful for analyzing coexpression of several genes (7,17,21,23) ( Figure IF) . Since radioactive probes appear generally to be more sensitive than biotinylated probes, radioactive probes are favored for detecting less abundant mRNA.
Problems and Pitfalls
The non-radioactive probes, including the biotinylated ones, currently have two disadvantages. First, they are generally considered to be less sensitive than the corresponding radioactive probes. This precludes the use of non-radioactive probes for the detection of low-abundance "As.
For example, many neuropeptide mRNAs can be detected with biotinylated probes, whereas radioactive probes are necessary in most instances to detect the less abundant mRNAs coding for neurotransmitter receptors (17) . Nevertheless, improvements in the sensitivity of biotinylated probes can still be obtained by increasing the number of reporter molecules attached to the probe (6) and/or improving the detection systems (19, 25) , including in situ PCR (20, 22) . With multistep detection systems and appropriate protocols, biotinylated probes can provide a degree of sensitivity equivalent to radioactive probes, which reportedly is on the order of a few viral genomes per cell (19, 26) . In addition, digoxigenin-labeled probes seem to have higher sensitivity than their corresponding biotinylated probes (7). A second disadvantage of biotinylated probes is that they are not as suitable for quantitative ISH, especially because standardization of the procedure and of the signal intensity is difficult. Nevertheless, several investigations suggest that quantitation can be reliably obtained in simple systems with biotinylated probes (12, 26, 29) .
Conclusion
At present, biotinylated probes are one of the most efficient techniques for non-radioactive ISH. Biotinylated probes have proven useful for ISH with a large variety of detection protocols for mRNA or viral genomes in many tissues. Improvements in sensitivity of the biotinylated probes are still feasible. Since biotinylated and digoxigenin probes are very efficient and simple to use for ISH, one must expect that such probes will compete with if not replace radioactive probes for mRNA detection in the near future, as is already the case for detection of DNA sequences on chromosomes (15) . 
